Viewing Study NCT01256801



Ignite Creation Date: 2024-05-05 @ 11:05 PM
Last Modification Date: 2024-10-26 @ 10:28 AM
Study NCT ID: NCT01256801
Status: COMPLETED
Last Update Posted: 2015-07-29
First Post: 2010-12-01

Brief Title: Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion
Sponsor: Peking University Cancer Hospital Institute
Organization: Peking University Cancer Hospital Institute

Study Overview

Official Title: Gene Expression Profiling of Breast Cancer Cells in Pleural Effusion Prodict the Response of Malignant Pleural Effusion to Immunotherapy
Status: COMPLETED
Status Verified Date: 2015-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GMPE
Brief Summary: The investigators want to develop a gene expression profile for the prediction of immunotherapy response of patients with metastatic breast cancer presenting malignant pleural effusion
Detailed Description: 1 The patiets with malignant pleural effusion are randomizned to be treated with cytokinsinteleukin 2 or dendritic cellsDC plus cytokine induced killer cellsCIK locally
2 Malignant pleural effusion from metastatic breast cancer patient is obtained through thoracentesis and is centrifugalized to enrich cancer cells before the therapy
3 The enriched cancer cells are flash frozen and stored at -80 until processing
4 The gene expression in pleural effusion is detected by microarray to screen gene markers that are differently expressed between groups
5 Statistical analysis is performed using unsupervised hierarchical cluster

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None